• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade.

作者信息

Winther K, Rein E

机构信息

Department of Clinical Chemistry, Hvidovre Hospital, Copenhagen, Denmark.

出版信息

Eur Heart J. 1990 Sep;11(9):819-23. doi: 10.1093/oxfordjournals.eurheartj.a059802.

DOI:10.1093/oxfordjournals.eurheartj.a059802
PMID:1977586
Abstract

Moderate exercise increased platelet aggregability of 12 middle-aged men with stable angina pectoris: the mean ADP threshold fell from 4.58 +/- 0.63 to 3.18 +/- 0.41 microM, P less than 0.01. Exercise did not, however, alter platelet aggregability in 12 healthy matched controls. Physical effort approximately doubled the plasma levels of adrenaline and noradrenaline in patients as well as in controls. Under the same conditions the cAMP content of platelets fell in the angina group from 20.86 +/- 1.86 to 17.78 +/- 1.71 pmol 10(-9) platelets, P less than 0.01, while there was no change in control levels. The fall of cAMP could account for the observed increase in platelet aggregability. We speculate that the increased aggregability of platelets in the exercising anginal subjects represents an imbalance between prostacyclin release and haemodynamic changes. The beta 1-selective blocker metoprolol, in usual therapeutic dosages, prevented the observed platelet changes probably by minimizing the haemodynamic disturbances and stimulating release of prostacyclin.

摘要

相似文献

1
Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade.
Eur Heart J. 1990 Sep;11(9):819-23. doi: 10.1093/oxfordjournals.eurheartj.a059802.
2
Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.
Am J Cardiol. 1995 Jan 1;75(1):1-6. doi: 10.1016/s0002-9149(99)80516-5.
3
Differential effects of timolol and metoprolol on platelet function at rest and during exercise.噻吗洛尔和美托洛尔对静息及运动时血小板功能的不同影响。
Eur J Clin Pharmacol. 1988;33(6):587-92. doi: 10.1007/BF00542492.
4
The effect of beta-blockade on platelet function and fibrinolytic activity.
J Cardiovasc Pharmacol. 1987;10 Suppl 2:S94-8; discussion S99.
5
Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls.精神和身体应激对稳定型心绞痛患者及健康对照者血小板功能的影响。
Eur Heart J. 1997 May;18(5):807-15. doi: 10.1093/oxfordjournals.eurheartj.a015346.
6
The effect of exercise on platelet beta-adrenoceptor function and platelet aggregation in healthy human volunteers.运动对健康人类志愿者血小板β-肾上腺素能受体功能及血小板聚集的影响。
Clin Physiol. 1988 Apr;8(2):147-53. doi: 10.1111/j.1475-097x.1988.tb00203.x.
7
Inhibition of platelet aggregation by prostacyclin is attenuated after exercise in patients with angina pectoris.在患有心绞痛的患者中,运动后前列环素对血小板聚集的抑制作用减弱。
Am Heart J. 1992 Feb;123(2):291-7. doi: 10.1016/0002-8703(92)90637-b.
8
Effects of three beta-blockers with different pharmacodynamic properties on platelet aggregation and platelet and plasma cyclic AMP.三种具有不同药效学特性的β受体阻滞剂对血小板聚集以及血小板和血浆环磷酸腺苷的影响。
Eur J Clin Pharmacol. 1988;35(1):17-20. doi: 10.1007/BF00555501.
9
Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina.劳力性心绞痛患者在跑步机运动后高切应力下血小板聚集性增强。
Thromb Haemost. 1996 May;75(5):833-7.
10
Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.氯吡格雷可抑制服用阿司匹林的稳定型慢性心绞痛患者的血小板聚集。
Int J Cardiol. 2008 Jan 11;123(2):195-6. doi: 10.1016/j.ijcard.2006.11.136. Epub 2007 Feb 22.

引用本文的文献

1
Lack of interaction of ketoprofen with warfarin.酮洛芬与华法林无相互作用。
Eur J Clin Pharmacol. 1993;44(2):205-6. doi: 10.1007/BF00315483.
2
Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation.
Eur J Clin Pharmacol. 1992;42(4):413-21. doi: 10.1007/BF00280128.
3
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.控释美托洛尔制剂。其药效学和药代动力学特性以及在高血压和缺血性心脏病治疗中的应用综述。
Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006.